18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer - Bertin Instruments

    Scientific publications

    18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer

    Eliot T McKinley1, Joseph E Bugaj2, Ping Zhao1, Saffet Guleryuz3, Christine Mantis2, Prafulla C Gokhale4, Robert Wild5, and H. Charles Manning3,*
    Sources: 1VUIIS, Vanderbilt University 2Molecular Imaging, OSI Pharmaceuticals 3Institute of Imaging Science, Vanderbilt University 4In vivo Pharmacology,, OSI Pharmaceuticals Inc 5In Vivo Pharmacology,, OSI Pharmaceuticals
    Clinical Cancer research,21, 2011; doi: 10.1158/1078-0432.CCR-10-2274

    Sample name

    Human tissues

    ANY QUESTIONS? CONTACT AN EXPERT

    Please fill in this form if you wish to contact our sales team or receive further information.

    My Account
    Forgot password ?

    Add a question !

    Add a question